Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-17

Clinical Trial Update: Memory Aid by Intranasal Insulin in Diabetes (MemAID) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MemAID investigating intranasal insulin in Type 2 diabetes; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MemAID (intranasal insulin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2021-09-17